Clinical Trial: MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonit
Brief Summary: A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder.
Detailed Summary:
Sponsor: MEDRx USA, Inc.
Current Primary Outcome: Mean of all 24 Current Pain Intensity scores collected on Days 2 through 7 on a 0-10 NPRS. [ Time Frame: 7 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: MEDRx USA, Inc.
Dates:
Date Received: July 12, 2010
Date Started: July 2010
Date Completion:
Last Updated: April 13, 2016
Last Verified: April 2016